Company Filing History:
Years Active: 2020
Title: Ting Qin - Innovator in Pharmaceutical Compounds
Introduction
Ting Qin is a notable inventor based in Nottingham, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential applications in cancer treatment.
Latest Patents
Ting Qin holds a patent for a pharmaceutical compound, specifically a benzimidazole of formula (I). This compound is characterized by a 5-membered heteroaryl group and is recognized for its activity in modulating the activity of p300 and/or CBP. It is particularly relevant in the treatment of cancer, with a focus on prostate cancer.
Career Highlights
Ting Qin is currently associated with Cellcentric Limited, where she continues to advance her research and development efforts in the pharmaceutical sector. Her work is instrumental in exploring innovative solutions for cancer treatment.
Collaborations
Ting collaborates with esteemed colleagues, including Neil Anthony Pegg and David Michel Adrien Taddei. Their combined expertise contributes to the success of their projects and the advancement of their research.
Conclusion
Ting Qin's innovative work in pharmaceutical compounds showcases her dedication to improving cancer treatment options. Her contributions are vital in the ongoing fight against cancer, particularly prostate cancer.